Ligand Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 28.8 | 76.8 | 158.4 |
| Net Receivables | 11.0 | 10.5 | 11.5 |
| Inventories | -- | 0.0 | 3.9 |
| Other Current Assets | 54.2 | 22.7 | 61.8 |
| Total Current Assets | 93.9 | 109.9 | 235.6 |
| Net Fixed Assets | 12.9 | 2.9 | 5.6 |
| Other Noncurrent Assets | 64.6 | 60.5 | 84.9 |
| Total Assets | 171.4 | 173.3 | 326.1 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 14.6 | 12.7 | 12.3 |
| Short-Term Debt | 12.8 | 1.5 | 39.9 |
| Other Current Liabilities | 43.2 | 36.8 | 118.6 |
| Total Current Liabilities | 70.6 | 51.0 | 170.8 |
| Long-Term Debt | 49.7 | 0.6 | 2.2 |
| Other Noncurrent Liabilities | 61.5 | 92.6 | 125.7 |
| Total Liabilities | 181.8 | 144.2 | 298.7 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | (10.4) | 29.1 | 27.4 |
| Total Equity | (10.4) | 29.1 | 27.4 |
| Shares Outstanding (mil.) | 113.0 | 113.0 | 113.0 |
© 2009 Morningstar, Inc. Financial Data provided by
